Humanin

What it is

Humanin is a 24-amino-acid peptide encoded within the mitochondrial DNA of the 16S ribosomal RNA gene. It is one of the family of mitochondrial-derived peptides (MDPs), discovered in 2001 by researchers studying neuroprotective factors in Alzheimer disease.

Humanin and related peptides represented a paradigm shift in understanding mitochondrial biology, demonstrating that mitochondria produce signaling peptides with effects on cellular survival, metabolism, and aging beyond their traditional role as energy producers.

Mechanism of action

Humanin’s effects span multiple cellular pathways:

• Cytoprotective effects: protects cells from various stressors including oxidative damage, ER stress, and apoptosis triggers
• Anti-apoptotic activity: inhibits the BAX-mediated apoptotic pathway through direct binding to BAX
• Insulin sensitizing effects: improves insulin action in cellular models
• Cardioprotective effects: protects cardiomyocytes from ischemic injury in preclinical models
• Decline with age: circulating humanin levels decline with age, paralleling the broader decline in mitochondrial function

Clinical evidence

Humanin research is largely preclinical. Animal studies have shown beneficial effects across various models including Alzheimer disease, type 2 diabetes, atherosclerosis, and ischemic injury. Human clinical trials are limited; most current clinical use is informed by preclinical evidence and the broader MDP research framework.

Why we don’t prescribe it at The Tide

The clinical evidence base for therapeutic humanin use in humans is not yet sufficient to support routine prescribing. The biology is genuinely interesting and the mechanism story is compelling, but the gap between preclinical promise and human clinical validation remains substantial. We monitor this research area and may incorporate humanin-related interventions as clinical evidence develops.

For metabolic and longevity-focused interventions where humanin’s mechanisms might be relevant, we currently prescribe MOTS-c (a different mitochondrial-derived peptide with somewhat more clinical research) and use foundational interventions including exercise, sleep optimization, and metabolic optimization.

Side effects and contraindications

Limited human safety data. Avoided in pregnancy, breastfeeding, malignancy as a precaution given the cytoprotective and anti-apoptotic mechanisms.